Specialized Self-Emulsifying Cannabidiol Formulations for Niche Applications

Publication ID: 24-11857678_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Self-Emulsifying Cannabidiol Formulations for Niche Applications,” Published Technical Disclosure No. 24-11857678_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857678_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,678.

Summary of the Inventive Concept

This inventive concept adapts self-emulsifying cannabidiol formulations for specific, narrow markets or unique operational environments, addressing high-security needs, disaster relief, extreme weather conditions, and compromised immune systems.

Background and Problem Solved

The original patent disclosed self-emulsifying cannabidiol compositions, but these formulations may not be suitable for all situations. The present inventive concept addresses the limitations of the original patent by providing specialized formulations and systems for niche applications, ensuring effective treatment in challenging environments.

Detailed Description of the Inventive Concept

The inventive concept comprises four primary variations: 1) a system for treating patients in remote or disaster-stricken areas, featuring a portable, waterproof storage container; 2) a method for providing emergency relief, involving rapid absorption and relief from withdrawal symptoms; 3) a self-emulsifying cannabidiol composition for use in high-security environments, incorporating tamper-evident or tamper-resistant packaging; and 4) a system for delivering self-emulsifying cannabidiol compositions in extreme weather conditions, utilizing weather-resistant packaging and temperature control elements.

Novelty and Inventive Step

The novelty of the present inventive concept lies in the adaptation of self-emulsifying cannabidiol formulations for specific, niche applications. The inventive step involves the combination of specialized packaging, storage, and delivery systems with the original self-emulsifying cannabidiol composition, enabling effective treatment in challenging environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include, but are not limited to, self-emulsifying cannabidiol compositions for use in veterinary medicine, agricultural applications, or space exploration. Variations may also involve different packaging materials, temperature control mechanisms, or administration routes.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including pharmaceuticals, disaster relief, and high-security environments. Target markets may include government agencies, emergency response organizations, and specialized healthcare providers.

CPC Classifications

SectionClassGroup
A A61 A61K9/107
A A61 A61K9/4808
A A61 A61K9/4825
A A61 A61K31/05
A A61 A61K47/10
A A61 A61K47/14
A A61 A61K47/22

Field of Art

Pharmaceutical formulations, specifically self-emulsifying drug delivery systems for cannabidiol with a focus on composition design, packaging, and administration methods for medical treatments

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical formulation scientist with expertise in drug delivery systems, emulsion technologies, packaging design, and cannabinoid-based medical treatments, holding advanced degrees in pharmaceutical sciences or chemical engineering

Obviousness Rationale

A PHOSITA would recognize that the published technical disclosure represents predictable variations of the source patent's core self-emulsifying cannabidiol composition by applying standard pharmaceutical engineering techniques to address specific environmental and operational challenges. The disclosed variations demonstrate routine adaptations of known formulation principles to niche application contexts, utilizing standard packaging and delivery modifications well within the ordinary skill of pharmaceutical formulation experts.

Obvious Combinations & Variations

Source Patent Element
Self-emulsifying cannabidiol composition with 1-40% cannabidiol and surfactant systems
PTD Variation
Adapting the composition for disaster relief and remote area treatment with portable, waterproof storage containers
Obviousness Reasoning
A PHOSITA would find it obvious to modify packaging to enhance portability and protect the formulation, as pharmaceutical packaging design is a predictable solution for environmental challenges
Source Patent Element
Composition capable of forming emulsions with 100-300 nanometer globule sizes in aqueous media
PTD Variation
Developing formulations with enhanced bioavailability for patients with compromised immune systems
Obviousness Reasoning
Optimizing drug delivery for specific patient populations represents a standard pharmaceutical engineering approach using known emulsion technology principles
Source Patent Element
Cannabidiol composition with surfactants and potential antioxidant additives
PTD Variation
Incorporating tamper-evident packaging for high-security environments
Obviousness Reasoning
Implementing security-focused packaging modifications is a predictable design choice for pharmaceutical products, representing a routine solution to protect sensitive formulations
Source Patent Element
Self-emulsifying composition with temperature-sensitive components
PTD Variation
Adding temperature control elements for extreme weather condition delivery
Obviousness Reasoning
Developing temperature-stabilized drug delivery systems is a well-known technique in pharmaceutical formulation for maintaining product integrity across varied environmental conditions
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would be considered obvious to a person having ordinary skill in the art at the time of invention, when viewed in light of US Patent 11857678. The published technical disclosure demonstrates predictable extensions of the source patent's self-emulsifying cannabidiol composition through routine pharmaceutical engineering modifications that would be apparent to a skilled practitioner without requiring inventive insight.

Original Patent Information

Patent NumberUS 11,857,678
TitleSelf-emulsifying cannabidiol formulations
Assignee(s)Benuvia Operations, LLC